JP2017522319A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522319A5 JP2017522319A5 JP2017502625A JP2017502625A JP2017522319A5 JP 2017522319 A5 JP2017522319 A5 JP 2017522319A5 JP 2017502625 A JP2017502625 A JP 2017502625A JP 2017502625 A JP2017502625 A JP 2017502625A JP 2017522319 A5 JP2017522319 A5 JP 2017522319A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 48
- 229920001184 polypeptide Polymers 0.000 claims description 46
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 46
- 101710186862 Factor H binding protein Proteins 0.000 claims description 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 14
- 230000004927 fusion Effects 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 8
- 230000002163 immunogen Effects 0.000 claims description 7
- 241000124008 Mammalia Species 0.000 claims description 4
- 241000699670 Mus sp. Species 0.000 claims description 4
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims description 2
- 208000034762 Meningococcal Infections Diseases 0.000 claims description 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 2
- 241000588650 Neisseria meningitidis Species 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- -1 linker amino acid Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14177563 | 2014-07-17 | ||
| EP14177563.5 | 2014-07-17 | ||
| PCT/EP2015/066229 WO2016008961A1 (en) | 2014-07-17 | 2015-07-16 | Meningococcus vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020066808A Division JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522319A JP2017522319A (ja) | 2017-08-10 |
| JP2017522319A5 true JP2017522319A5 (OSRAM) | 2018-08-23 |
| JP6687597B2 JP6687597B2 (ja) | 2020-04-22 |
Family
ID=51178811
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502625A Active JP6687597B2 (ja) | 2014-07-17 | 2015-07-16 | 髄膜炎菌ワクチン |
| JP2020066808A Active JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020066808A Active JP7074793B2 (ja) | 2014-07-17 | 2020-04-02 | 髄膜炎菌ワクチン |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11707513B2 (OSRAM) |
| EP (1) | EP3169358A1 (OSRAM) |
| JP (2) | JP6687597B2 (OSRAM) |
| KR (2) | KR20230012100A (OSRAM) |
| CN (2) | CN106659776A (OSRAM) |
| AR (2) | AR101225A1 (OSRAM) |
| AU (2) | AU2015289193A1 (OSRAM) |
| BE (1) | BE1022878B1 (OSRAM) |
| BR (1) | BR112017000519A2 (OSRAM) |
| CA (1) | CA2954729C (OSRAM) |
| EA (1) | EA038940B1 (OSRAM) |
| IL (1) | IL249823B (OSRAM) |
| MX (1) | MX2017000775A (OSRAM) |
| SG (2) | SG11201610946YA (OSRAM) |
| WO (1) | WO2016008961A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2940447C (en) | 2014-02-28 | 2023-07-11 | Glaxosmithkline Biologicals Sa | Modified meningococcal fhbp polypeptides |
| EA201692552A1 (ru) | 2014-07-17 | 2017-06-30 | Глаксосмитклайн Байолоджикалс С.А. | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| AR101225A1 (es) | 2014-07-17 | 2016-11-30 | Glaxosmithkline Biologicals Sa | Vacunas de meningococos |
| WO2017075189A1 (en) * | 2015-10-27 | 2017-05-04 | University Of Massachusetts | Factor h-fc immunotherapy |
| CN107961370B (zh) * | 2017-03-22 | 2020-08-11 | 武汉博沃生物科技有限公司 | 多价肺炎球菌缀合疫苗及其制备方法 |
| CN108939061A (zh) * | 2018-08-03 | 2018-12-07 | 北京智飞绿竹生物制药有限公司 | 一种多组分b群脑膜炎球菌疫苗及其制备方法 |
| EP3607967A1 (en) * | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| US11014736B2 (en) | 2019-04-18 | 2021-05-25 | Altria Client Services Llc | Sliding packs with flip top hinged lids |
| CN110804101A (zh) * | 2019-11-08 | 2020-02-18 | 苏州微超生物科技有限公司 | B群脑膜炎球菌相关融合蛋白、疫苗及其制备方法与应用 |
| EP4065595A4 (en) | 2019-11-25 | 2023-12-20 | Griffith University | IMMUNOGENIC PROTEIN AGAINST GONOCOCCAL INFECTION |
| GB202115151D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Methods |
| WO2025077793A1 (zh) * | 2023-10-10 | 2025-04-17 | 康希诺生物股份公司 | 一种抗脑膜炎球菌的免疫组合物及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6747137B1 (en) | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| EP2275129A3 (en) * | 2000-01-17 | 2013-11-06 | Novartis Vaccines and Diagnostics S.r.l. | Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0419408D0 (en) | 2004-09-01 | 2004-10-06 | Chiron Srl | 741 chimeric polypeptides |
| GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| EP2493499A1 (en) | 2009-10-27 | 2012-09-05 | Novartis AG | Modified meningococcal fhbp polypeptides |
| JP2013521326A (ja) * | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| BR122021020829B8 (pt) | 2010-03-30 | 2022-12-27 | Children´S Hospital & Res Center At Oakland | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| GB201120634D0 (en) | 2011-11-30 | 2012-01-11 | Univ Sheffield | Adjuvant polypeptide |
| US10376573B2 (en) * | 2012-06-14 | 2019-08-13 | Glaxosmithkline Biologicals Sa | Vaccines for serogroup X meningococcus |
| GB201215005D0 (en) | 2012-08-23 | 2012-10-10 | Isis Innovation | Stabilised meningitis vaccine |
| CA2940447C (en) * | 2014-02-28 | 2023-07-11 | Glaxosmithkline Biologicals Sa | Modified meningococcal fhbp polypeptides |
| EP2916512B1 (en) | 2014-03-07 | 2016-08-24 | Mitsubishi Electric R&D Centre Europe B.V. | Method for classifying a TCP connection carrying HTTP traffic as a trusted or an untrusted TCP connection |
| EA201692552A1 (ru) | 2014-07-17 | 2017-06-30 | Глаксосмитклайн Байолоджикалс С.А. | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| AR101225A1 (es) | 2014-07-17 | 2016-11-30 | Glaxosmithkline Biologicals Sa | Vacunas de meningococos |
| US11767338B2 (en) | 2018-06-21 | 2023-09-26 | Basf Se | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers |
-
2015
- 2015-07-16 AR ARP150102269A patent/AR101225A1/es not_active Application Discontinuation
- 2015-07-16 EP EP15738900.8A patent/EP3169358A1/en active Pending
- 2015-07-16 KR KR1020237001115A patent/KR20230012100A/ko not_active Ceased
- 2015-07-16 WO PCT/EP2015/066229 patent/WO2016008961A1/en not_active Ceased
- 2015-07-16 CN CN201580038773.1A patent/CN106659776A/zh active Pending
- 2015-07-16 MX MX2017000775A patent/MX2017000775A/es unknown
- 2015-07-16 CA CA2954729A patent/CA2954729C/en active Active
- 2015-07-16 KR KR1020177004245A patent/KR102626831B1/ko active Active
- 2015-07-16 SG SG11201610946YA patent/SG11201610946YA/en unknown
- 2015-07-16 CN CN202111134597.5A patent/CN113827712A/zh active Pending
- 2015-07-16 AU AU2015289193A patent/AU2015289193A1/en not_active Abandoned
- 2015-07-16 BE BE2015/5455A patent/BE1022878B1/fr not_active IP Right Cessation
- 2015-07-16 EA EA201692554A patent/EA038940B1/ru unknown
- 2015-07-16 JP JP2017502625A patent/JP6687597B2/ja active Active
- 2015-07-16 BR BR112017000519A patent/BR112017000519A2/pt not_active Application Discontinuation
- 2015-07-16 IL IL249823A patent/IL249823B/en unknown
- 2015-07-16 SG SG10201900041VA patent/SG10201900041VA/en unknown
- 2015-07-16 US US15/319,665 patent/US11707513B2/en active Active
-
2019
- 2019-02-18 AU AU2019201131A patent/AU2019201131C1/en active Active
-
2020
- 2020-04-02 JP JP2020066808A patent/JP7074793B2/ja active Active
-
2023
- 2023-06-06 US US18/329,701 patent/US12485164B2/en active Active
- 2023-10-17 AR ARP230102768A patent/AR130778A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522319A5 (OSRAM) | ||
| RU2015122368A (ru) | Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа | |
| Yano et al. | An ingenious design for peptide vaccines | |
| RU2010138815A (ru) | МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP | |
| JP2008530245A5 (OSRAM) | ||
| JP2015212284A5 (OSRAM) | ||
| WO2020234300A1 (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| TW201408691A (zh) | 分枝桿菌抗原疫苗 | |
| HRP20161710T1 (hr) | Identifikacija, optimizacija i uporaba kriptičkih hla-a24 etiopa za imunoterapiju | |
| JP2012501959A5 (OSRAM) | ||
| PT1651166E (pt) | Polipeptidos para indução de uma resposta imunitária de protecção contra staphylococcus aureus | |
| JP2019526274A5 (OSRAM) | ||
| WO2009099777A3 (en) | Chimeric hiv fusion proteins as vaccines | |
| JP2018507860A (ja) | 抗原特異的ｔ細胞反応を誘発するための、免疫原性タンパク質及びアジュバントの組み合わせを含むワクチン組成物 | |
| KR20160088323A (ko) | S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드 | |
| Vadesilho et al. | Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae | |
| RU2016108139A (ru) | Композиция neisseria meningitidis и способ индуцирования иммунного ответа | |
| US20230399364A1 (en) | Immunogenic Coronavirus Fusion Proteins and Related Methods | |
| EP3818989A1 (en) | Peptides and oligonucleotides for a sars-cov-2 vaccine | |
| WO2016196383A1 (en) | Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases | |
| WO2009129521A3 (en) | Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization | |
| JP2010535504A5 (OSRAM) | ||
| JP2016515516A5 (OSRAM) | ||
| RU2010126154A (ru) | Эпитопные пептиды stat3 | |
| Yano et al. | A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines |